Kinetics of Amyloid Aggregation: A Study of the GNNQQNY Prion Sequence

• Published in: PLoS computational biology Vol. 8; no. 11; p. e1002782
• Main Authors: Nasica-Labouze, Jessica, Mousseau, Normand
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01.11.2012; Public Library of Science (PLoS)
• Subjects: Aggregates; Amino Acid Sequence; Amyloid - chemistry; Amyloid - metabolism; Amyloid - ultrastructure; Biochemical Phenomena; Biology; Chemistry; Computational Biology; Experiments; Glycoproteins; Growth kinetics; Kinetics; Molecular Dynamics Simulation; Numerical analysis; Oligopeptides - chemistry; Oligopeptides - metabolism; Physics; Polymorphism; Prions; Properties; Proteins; Structure; Studies; Toxicity; Canada; Amino Acid Sequence; Biochemical Processes; Oligopeptides; Computational Biology; Amyloid; Kinetics; Molecular Dynamics Simulation
• ISSN: 1553-7358; 1553-734X; 1553-7358
• DOI: 10.1371/journal.pcbi.1002782

The small amyloid-forming GNNQQNY fragment of the prion sequence has been the subject of extensive experimental and numerical studies over the last few years. Using unbiased molecular dynamics with the OPEP coarse-grained potential, we focus here on the onset of aggregation in a 20-mer system. With a total of 16.9 μs of simulations at 280 K and 300 K, we show that the GNNQQNY aggregation follows the classical nucleation theory (CNT) in that the number of monomers in the aggregate is a very reliable descriptor of aggregation. We find that the critical nucleus size in this finite-size system is between 4 and 5 monomers at 280 K and 5 and 6 at 300 K, in overall agreement with experiment. The kinetics of growth cannot be fully accounted for by the CNT, however. For example, we observe considerable rearrangements after the nucleus is formed, as the system attempts to optimize its organization. We also clearly identify two large families of structures that are selected at the onset of aggregation demonstrating the presence of well-defined polymorphism, a signature of amyloid growth, already in the 20-mer aggregate.